Common virus kills cancer

	Tweet

A common virus that is harmless to people can destroy cancerous cells in the body and might be developed into a new cancer therapy, a new study suggests.

The virus, called adeno-associated virus type 2, or AAV-2, infects an estimated 80 percent of the population.

“Our results suggest that adeno-associated virus type 2, which infects the majority of the population but has no known ill effects, kills multiple types of cancer cells yet has no effect on healthy cells,” said Craig Meyers, a professor of microbiology and immunology at the Penn State College of Medicine in Pennsylvania.

"We believe that AAV-2 recognizes that the cancer cells are abnormal and destroys them. This suggests that AAV-2 has great potential to be developed as an anti-cancer agent,” Meyers said in a statement.

He said at a meeting of the American Society for Virology that studies have shown women infected with AAV-2 who are also infected with a cancer-causing wart virus called HPV develop Cervical cancer less frequently than uninfected women do.

AAV-2 is a small virus that cannot replicate itself without the help of another virus. But with the help of a second virus it kills cells.

For their study, Meyers and colleagues first infected a batch of human cells with HPV, some strains of which cause Cervical cancer.

They then infected these cells and normal cells with AAV-2.

After six days, all the HPV-infected cells died.

The same thing happened with Cervical, breast, prostate and squamous cell tumor cells.

All are cancers of the epithelial cells, which include skin cells and other cells that line the insides and outsides of organs.

“One of the most compelling findings is that AAV-2 appears to have no pathologic effects on healthy cells,” Meyers said.

“So many cancer therapies are as poisonous to healthy cells as they are to cancer cells. A therapy that is able to distinguish between healthy and cancer cells could be less difficult to endure for those with cancer.”

AAV-2 is being studied intensively as a gene therapy vector - a virus modified to carry disease-correcting genes into the body. Gene therapy researchers favor it because it does not seem to cause disease or immune system reaction on its own.

RELATED STORIES:
Cervical cancer screening: Too many are left unprotected   Glaxo HPV vaccine shows promise for women 26-55   Adding test for cervical cancer raises costs: study   Doctors say HPV vaccine should be given to everyone   Cervical cancer vaccine gives long protection   Coils almost halve risk of cervical cancer: study   Newer cervical cancer test no better than the old?   Gardasil prevents cervical cancer caused by virus   Fewer than 3 doses of cervical cancer vaccine effective   Aggressive vaccine effort could cut cervical cancer   US FDA approves Hycamtin for cervical cancer   CDC recommends human papillomavirus virus vaccination   Cervical disease sufferers could benefit from HPV vaccine   Genetic Differences Help Protect Against Cervical Cancer   “Screen and treat” cervical cancer programs effective in poorly resourced areas   Weakened RNA Interference Reduces Survival in Ovarian Cancer   Gates backs cervical cancer vaccines for poor   High cervical cancer rates sign of larger problems   New cervical cancer vaccine offers women 100% protection   Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia   Newly Created Cancer Stem Cells Could Aid Breast Cancer Research   $11.5 Million Cervical Cancer Grant Awarded to UAB Cancer Center, Partners

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]